{
    "Trade/Device Name(s)": [
        "QUANTA Lite\u2122 h-tTG Screen"
    ],
    "Submitter Information": "INOVA Diagnostics, Inc.",
    "510(k) Number": "K073145",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011566",
        "K011570"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM"
    ],
    "Summary Letter Date": "February 12, 2008",
    "Summary Letter Received Date": "February 6, 2008",
    "Submission Date": "February 5, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-human tissue transglutaminase IgG",
        "Anti-human tissue transglutaminase IgA"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microplate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "Semi-quantitative antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Lite\u2122 h-tTG Screen ELISA for semi-quantitative detection of IgA and IgG antibodies to tissue transglutaminase for celiac disease and dermatitis herpetiformis diagnosis",
    "Indications for Use Summary": "Enzyme-linked immunosorbent assay for semi-quantitative detection of IgA and IgG antibodies to tissue transglutaminase in human serum, aiding diagnosis of celiac disease (including IgA deficiency) and dermatitis herpetiformis in conjunction with other findings",
    "fda_folder": "Immunology"
}